The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...
Home »
NDTV News - India-news
» Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
No comments:
Post a Comment